Blue Trust’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
Other funds holding SLS
DI
Blue Trust's SLS Position: Q3 2026 in Review
Blue Trust sold out of SELLAS Life Sciences (SLS) in Q3 2026, closing a stake of 400 shares — an estimated $5.9K sold.
Blue Trust first reported a position in SLS in Q2 2026 and held it in 1 quarter. The position peaked at $5.9K in Q2 2026. 168 funds tracked by Wall St. Rank hold SLS as of Q3 2026.
- Blue Trust reported no remaining SELLAS Life Sciences position as of Q3 2026 after selling out during the quarter.
- Blue Trust sold 400 SELLAS Life Sciences shares in Q3 2026, an estimated $5.9K.
- Blue Trust first reported a position in SELLAS Life Sciences in Q2 2026 and held it in 1 quarter.
- Blue Trust's SELLAS Life Sciences position peaked at $5.9K in Q2 2026.
- 168 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.